Provided by Tiger Trade Technology Pte. Ltd.

PTC Therapeutics

70.56
+1.021.47%
Volume:691.02K
Turnover:48.59M
Market Cap:5.89B
PE:-115.67
High:70.84
Open:69.42
Low:69.05
Close:69.54
52wk High:90.87
52wk Low:49.38
Shares:83.46M
Float Shares:77.19M
Volume Ratio:1.00
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6100
EPS(LYR):7.78
ROE:-7740.12%
ROA:2.46%
PB:-35.61
PE(LYR):9.07

Loading ...

May 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Major Issues Report

Form 8-K - Current report
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 11, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 27, 2023

Major Issues Report

8-K - Current report
Apr 27, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 21, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 21, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 18, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 18, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 18, 2023

Major Issues Report

8-K - Current report
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 31, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 29, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 27, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 27, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities